A citation-based method for searching scientific literature

E Conde, B Angulo, E Izquierdo, L Paz-Ares, C Belda-Iniesta, M Hidalgo, F López-Ríos. Clin Transl Oncol 2013
Times Cited: 20







List of co-cited articles
166 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer.
Benjamin J Solomon, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Tarek Mekhail, Enriqueta Felip, Federico Cappuzzo, Jolanda Paolini, Tiziana Usari, Yiyun Tang,[...]. J Clin Oncol 2018
146
10

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Benjamin P Levy, Marc D Chioda, Dana Herndon, John W Longshore, Mohamed Mohamed, Sai-Hong Ignatius Ou, Craig Reynolds, Jaspal Singh, Ignacio I Wistuba, Paul A Bunn,[...]. Oncologist 2015
20
10

Liquid biopsy for lung cancer early detection.
Mariacarmela Santarpia, Alessia Liguori, Alessandro D'Aveni, Niki Karachaliou, Maria Gonzalez-Cao, Maria Grazia Daffinà, Chiara Lazzari, Giuseppe Altavilla, Rafael Rosell. J Thorac Dis 2018
46
10

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.
Zofia Piotrowska, Hideko Isozaki, Jochen K Lennerz, Justin F Gainor, Inga T Lennes, Viola W Zhu, Nicolas Marcoux, Mandeep K Banwait, Subba R Digumarthy, Wenjia Su,[...]. Cancer Discov 2018
149
10


Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.
C Lim, H S Sekhon, J C Cutz, D M Hwang, S Kamel-Reid, R F Carter, G da Cunha Santos, T Waddell, M Binnie, M Patel,[...]. Curr Oncol 2017
15
13

Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, Jonas Leichsenring, Sabine Merkelbach-Bruse, Julia Glade, Michael Hummel, Fabian Stögbauer, Annika Lehmann, Marcel Trautmann,[...]. Genes Chromosomes Cancer 2020
24
10

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
P Garrido, E Conde, J de Castro, J J Gómez-Román, E Felip, L Pijuan, D Isla, J Sanz, L Paz-Ares, F López-Ríos. Clin Transl Oncol 2020
19
10

ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer.
Theresa A Boyle, Katsuhiro Masago, Kim E Ellison, Yasushi Yatabe, Fred R Hirsch. Clin Lung Cancer 2015
37
10

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
Sylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, Nicolas Girard, Fred R Hirsch, Anja C Roden, Fernando Lopez-Rios, Deepali Jain, Teh-Ying Chou, Noriko Motoi,[...]. J Thorac Oncol 2020
69
10

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
Lénaïg Mescam-Mancini, Sylvie Lantuéjoul, Denis Moro-Sibilot, Isabelle Rouquette, Pierre-Jean Souquet, Clarisse Audigier-Valette, Jean-Christophe Sabourin, Chantal Decroisette, Linda Sakhri, Elisabeth Brambilla,[...]. Lung Cancer 2014
80
10


ROS1-dependent cancers - biology, diagnostics and therapeutics.
Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A Davare. Nat Rev Clin Oncol 2021
14
14

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Véronique Hofman, Isabelle Rouquette, Elodie Long-Mira, Nicolas Piton, Emmanuel Chamorey, Simon Heeke, Jean Michel Vignaud, Clémence Yguel, Julien Mazières, Anne-Laure Lepage,[...]. J Thorac Oncol 2019
14
14

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
351
10

Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.
Carolyn C Compton, James A Robb, Matthew W Anderson, Anna B Berry, George G Birdsong, Kenneth J Bloom, Philip A Branton, Jessica W Crothers, Allison M Cushman-Vokoun, David G Hicks,[...]. Arch Pathol Lab Med 2019
30
10

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
5

Evaluation of 2 real-time PCR assays for in vitro diagnostic use in the rapid and multiplex detection of EGFR gene mutations in NSCLC.
Anthony T C Wong, Rene M Y To, Chris L P Wong, Wai-Kong Chan, Edmond S K Ma. Diagn Mol Pathol 2013
12
8

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib.
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, Debbie Mair, Rebeca Martinez, Esther Conde, Felice Shieh, Jeffrey Vaks, Rachel Langland, H Jeffrey Lawrence,[...]. PLoS One 2013
40
5

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Carmen J Allegra, J Milburn Jessup, Mark R Somerfield, Stanley R Hamilton, Elizabeth H Hammond, Daniel F Hayes, Pamela K McAllister, Roscoe F Morton, Richard L Schilsky. J Clin Oncol 2009
896
5

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Christos S Karapetis, Shirin Khambata-Ford, Derek J Jonker, Chris J O'Callaghan, Dongsheng Tu, Niall C Tebbutt, R John Simes, Haji Chalchal, Jeremy D Shapiro, Sonia Robitaille,[...]. N Engl J Med 2008
5

Clinical validation of a PCR assay for the detection of EGFR mutations in non-small-cell lung cancer: retrospective testing of specimens from the EURTAC trial.
Susana Benlloch, Maria Luisa Botero, Jordi Beltran-Alamillo, Clara Mayo, Ana Gimenez-Capitán, Itziar de Aguirre, Cristina Queralt, Jose Luis Ramirez, Santiago Ramón y Cajal, Barbara Klughammer,[...]. PLoS One 2014
26
5

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.
Keith T Flaherty, Jeffery R Infante, Adil Daud, Rene Gonzalez, Richard F Kefford, Jeffrey Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Nageatte Ibrahim,[...]. N Engl J Med 2012
5

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.
D Gonzalez de Castro, P A Clarke, B Al-Lazikani, P Workman. Clin Pharmacol Ther 2013
158
5

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Georgina V Long, Uwe Trefzer, Michael A Davies, Richard F Kefford, Paolo A Ascierto, Paul B Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain Algazi,[...]. Lancet Oncol 2012
594
5

Somatic activation of KIT in distinct subtypes of melanoma.
John A Curtin, Klaus Busam, Daniel Pinkel, Boris C Bastian. J Clin Oncol 2006
5

Cancer genomics: from discovery science to personalized medicine.
Lynda Chin, Jannik N Andersen, P Andrew Futreal. Nat Med 2011
327
5

Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma.
Steven Anderson, Kenneth J Bloom, Dino U Vallera, Josef Rueschoff, Cliff Meldrum, Robert Schilling, Barbara Kovach, Ju Ruey-Jiuan Lee, Pam Ochoa, Rachel Langland,[...]. Arch Pathol Lab Med 2012
110
5

Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, Debbie Mair, Rebeca Martinez, Esther Conde, Felice Shieh, Julie Tsai, Jeffrey Vaks, Robert Current,[...]. J Clin Pathol 2013
42
5

Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays.
Kevin Qu, Qiulu Pan, Xi Zhang, Luis Rodriguez, Ke Zhang, Hairong Li, Albert Ho, Heather Sanders, Anthony Sferruzza, Shih-Min Cheng,[...]. J Mol Diagn 2013
37
5

Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
Sung Lee, Victoria H Brophy, Jianli Cao, Margot Velez, Corey Hoeppner, Stephen Soviero, H Jeffrey Lawrence. Virchows Arch 2012
40
5

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Axel Hauschild, Jean-Jacques Grob, Lev V Demidov, Thomas Jouary, Ralf Gutzmer, Michael Millward, Piotr Rutkowski, Christian U Blank, Wilson H Miller, Eckhart Kaempgen,[...]. Lancet 2012
5

Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
Alexandre Harlé, Benoit Busser, Marie Rouyer, Valentin Harter, Pascal Genin, Agnès Leroux, Jean-Louis Merlin. Virchows Arch 2013
33
5

Treatment implications of the emerging molecular classification system for melanoma.
Emanuela Romano, Gary K Schwartz, Paul B Chapman, Jedd D Wolchock, Richard D Carvajal. Lancet Oncol 2011
59
5

From genes to drugs: targeted strategies for melanoma.
Keith T Flaherty, F Stephen Hodi, David E Fisher. Nat Rev Cancer 2012
260
5

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
Jean-Yves Douillard, Kelly S Oliner, Salvatore Siena, Josep Tabernero, Ronald Burkes, Mario Barugel, Yves Humblet, Gyorgy Bodoky, David Cunningham, Jacek Jassem,[...]. N Engl J Med 2013
5



Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
5

A standardized framework for the validation and verification of clinical molecular genetic tests.
Christopher J Mattocks, Michael A Morris, Gert Matthijs, Elfriede Swinnen, Anniek Corveleyn, Els Dequeker, Clemens R Müller, Victoria Pratt, Andrew Wallace. Eur J Hum Genet 2010
110
5

Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
Johanne Lade-Keller, Kirsten M Rømer, Per Guldberg, Rikke Riber-Hansen, Lise Lotte Hansen, Torben Steiniche, Henrik Hager, Lasse S Kristensen. J Mol Diagn 2013
57
5

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent-Puig,[...]. Lancet Oncol 2010
5

Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
5


Methodological and practical challenges for personalized cancer therapies.
Ignacio I Wistuba, Juri G Gelovani, Jörg J Jacoby, Suzanne E Davis, Roy S Herbst. Nat Rev Clin Oncol 2011
107
5

Chipping away at the lung cancer genome.
William Pao, Katherine E Hutchinson. Nat Med 2012
153
5

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
Patrick O'Donnell, Jane Ferguson, Johnny Shyu, Robert Current, Taraneh Rehage, Julie Tsai, Mari Christensen, Ha Bich Tran, Sean Shih-Chang Chien, Felice Shieh,[...]. BMC Cancer 2013
28
5

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
D J Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram,[...]. N Engl J Med 2001
5

Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2012
5

Inhibition of mutated, activated BRAF in metastatic melanoma.
Keith T Flaherty, Igor Puzanov, Kevin B Kim, Antoni Ribas, Grant A McArthur, Jeffrey A Sosman, Peter J O'Dwyer, Richard J Lee, Joseph F Grippo, Keith Nolop,[...]. N Engl J Med 2010
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.